ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Second Edition, examines the framework governing approval of generic pharmaceuticals in the context of Paragraph IV ANDA litigation. This in-depth resource balances perspectives from both innovator and generic drug manufacturers. With its focus on current and developing case law, ANDA Litigation provides strategies and tactics for novice and experienced litigators engaged in all aspects of ANDA litigation.
Chapter 22, "Managing an ANDA Litigation," was authored by Sterne Kessler director Daniel E. Yonan, associate Jon E. Boljesic, and former Sterne Kessler attorney Jonathan M. Strang. Mr. Yonan also served as an Associate Editor for the entire 985-page treatise. "Managing an ANDA Litigation" provides practical strategies and tactics for litigators involved in various aspects of an ANDA litigation from assembling a litigation team and compiling a budget to interacting with experts and consultants, discovery, and trial organization.